Labiotech.eu

News and Trends 1 Mar 2017

Swedish Oncology Biotech makes a Large IPO for its Peptides

The Swedish company Oncopeptides raised €68M with its IPO on Nasdaq Stockholm, which will allow the company to push their compound into phase III trials. Oncopeptides was founded in 2000 and is focused on the development of its lead compound Ygalo. After the company started a Phase II trial in patients with late stage relapsed and refractory multiple […]

March 1, 2017 - 3 minutesmins - By Melanie De Almeida

cultured meat market 2020 1 e1488366878713

More News! 1 Mar 2017

Lab-Grown Meat Could Hit the Market as Soon as 2020

Cultured meat could be a sustainable, healthy and inexpensive food alternative in a future that might be closer than we think. We recently attended the 2nd International Conference on Cultured Meat, where we had the chance to meet the key players in this revolutionary field. There, we learned that cultured meat, grown in the lab without […]

March 1, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 1 Mar 2017

Scaling Up your Drug? Follow these 3 Steps to Succeed

As a biotech scales up from the lab to industry, data management is a key part of the process. Even if you manage to prove your concept, applying it to patients will increase the number of variables in the business process calculations exponentially. How do you keep track of them all? In the development of […]

March 1, 2017 - 5 minutesmins - By External Contributor

AC Immune Genentech crenezumab phase III

News and Trends 28 Feb 2017

Hopes are up: A Second Phase III Trial for Alzheimer’s Disease

The Swiss biotech AC Immune announced that its partner Genentech (Roche) will start a second phase III clinical trial for its Alzheimer’s therapy crenezumab. In 2006 AC Immune partnered up with Genentech to bring its amyloid beta (Aβ)-targeting antibody crenezumab into the clinic. Although the compound did not meet its co-primary enpoints in the large phase II ABBY trial, Genentech pushed […]

February 28, 2017 - 3 minutesmins - By Melanie De Almeida

Arsanis Adimab RSV monoclonal antibodies

News and Trends 28 Feb 2017

New Antibodies to Target the Respiratory Syncytial Virus

The two companies Arsanis and Adimab, both specialized in the development of monoclonal antibodies, have partnered up against respiratory syncytial virus (RSV). Their license agreement is backed by the Gates Foundation. The clinical-stage biotech Arsanis is developing monoclonal antibodies (mAbs) for the treatment of serious infectious diseases. The company announced that they have gained the exclusive worldwide […]

February 28, 2017 - 3 minutesmins - By Melanie De Almeida

Best in Biotech 28 Feb 2017

Stroopwaffels, Krokets and Biotechs – Meet the Top 10 in Leiden!

Known for its charming canals and tulip fields, Leiden is a major tourist attraction in the Netherlands. It is also home to the oldest Dutch university and harbours the leading biotech cluster in the country. Let’s have a look at the top 10 biotechs in Leiden! Not only is Leiden the birthplace of the famous painter Rembrandt, but it […]

February 28, 2017 - 7 minutesmins - By Melanie De Almeida

News and Trends 28 Feb 2017

It’s Global Rare Disease Day! What Cures is Biotech Cooking Up?

We’ve compiled a list of some of the latest advances of biotech in the field of rare disease to contribute to Rare Disease Day 2017. The European Organization for Rare Diseases (EURORDIS) is once again coordinating Rare Disease Day, which takes place on the last day of February every year. The aim is to raise awareness of […]

February 28, 2017 - 5 minutesmins - By Clara Rodríguez Fernández

UK Physical Sciences Rosalind Franklin Research Institute 1

More News! 27 Feb 2017

UK Lays Down a Foundation for Physical Science Innovation

The UK government announced a €117M (£100M) investment to join the forces in physical sciences, engineering and life sciences through the new Rosalind Franklin research institute (RFI). Rosalind Franklin, the British scientist whose use of X-rays to study biological structures played a crucial role in the discovery of the DNA ‘double helix’, has laid some of the cornerstones in biophysical […]

February 27, 2017 - 2 minutesmins - By Melanie De Almeida

Congenica Sapientia fundraising clinical genomics e1487935960201

More News! 27 Feb 2017

Fundraising in the UK will Support Rare Disease Diagnostics Worldwide

Congenica has raised £8M in its Series B financing round to sustain the international rollout of its clinical genome analysis platform Sapientia. Congenica is a genomic diagnostics company in Cambridge’s biotech cluster. Its genome analysis platform, Sapientia, takes on the challenge of interpreting the avalanche of genomic data becoming available in healthcare. The £8M (€9.5M) raised will sustain the […]

February 27, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Interview 27 Feb 2017

Meet the Woman developing the Next Generation of Insulin

Fiasp, ultra-fast-acting insulin, could revolutionize insulin. We chatted with Liselotte Hyveled, the woman heading the team behind it. “I didn’t get into nursing school, so I went into pharmacy instead,” Liselotte Hyveled laughs. “In Denmark, we have free education, but the government limits degrees for students based on job market needs. There was a low […]

February 27, 2017 - 7 minutesmins - By Evelyn Warner

BOM Gallery Laurie Ramsell Gina Czarnecki

News and Trends 25 Feb 2017

Art Made with Human DNA Explores the Future of Genetics in Birmingham

Gene Craft: Art in the Biogenetic Age opened this week at Birmingham Open Media (BOM) in the UK. Aiming to explore the social, economic and emotional implications of the most recent breakthroughs in genetics, the exhibition features two living art pieces created with human DNA by bioartists Laurie Ramsell and Gina Czarnecki. After the Human Fertilisation and Embryology Authority (HFEA) […]

February 25, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

bidirectional neuroprosthesis university of geneva unige

More News! 24 Feb 2017

Interfacing the Brain & Machines: Another Step to a Cyborg Future

Controlling robotic prostheses with one’s mind has been a hot topic in research, but making a prothesis ‘talk back’ has been a stumbling block. Researchers from Switzerland show progress in creating sensations from a bidirectional neuroprosthesis. Researchers from the University of Geneva, in Switzerland, are developing a new method to connect a prosthesis to neural activity […]

February 24, 2017 - 3 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Swedish Oncology Biotech makes a Large IPO for its Peptides

Lab-Grown Meat Could Hit the Market as Soon as 2020

Scaling Up your Drug? Follow these 3 Steps to Succeed

Hopes are up: A Second Phase III Trial for Alzheimer’s Disease

New Antibodies to Target the Respiratory Syncytial Virus

Stroopwaffels, Krokets and Biotechs – Meet the Top 10 in Leiden!

It’s Global Rare Disease Day! What Cures is Biotech Cooking Up?

UK Lays Down a Foundation for Physical Science Innovation

Fundraising in the UK will Support Rare Disease Diagnostics Worldwide

Meet the Woman developing the Next Generation of Insulin

Art Made with Human DNA Explores the Future of Genetics in Birmingham

Interfacing the Brain & Machines: Another Step to a Cyborg Future

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!